Dr. Mary McElroy is Associate Director of Discovery Toxicology and Pharmacology at Charles River Laboratories. In this capacity, Mary’s team run a range of in vivo lung pharmacology models and in vitro safety assessments studies including lung organotypic cultures for human relevant risk assessment by inhalation route. Prior to Charles River, Mary spent her career performing lung-related cell-biology, pharmacology, and toxicology. Mary has an MSc in Toxicology from University of Surrey, PhD in Human Lung Development from the University of Southampton, post-doctoral research on alveolar epithelial cell biology at University of California San Francisco, Lecturer/Group Leader positions at the Trinity Collage Dublin and University of Edinburgh. Mary is a European Registered Toxicologist and holds an MBA from the Open University.
WEBINAR: Secure Regulatory Approval of Complex Lung Models Through Collective Momentum
Regulatory agencies are increasingly embracing in vitro lung models. By integrating these advanced models, you can generate more human-relevant data, helping you streamline regulatory approvals and improve decision-making.
Watch the Replay
Articles:
- The Breath of Life is Complex (Eureka Blog)
- Taking Flight (Eureka Blog)
- Ebola Vaccines: Racing Against the Clock (Eureka Blog)
Publications: